These RNA networks intersect with major oncogenic pathways, including PI3K/AKT/mTOR signaling, hypoxia responses, and epigenetic regulators such as EZH2, thereby affecting key cancer processes such as proliferation, epithelial-mesenchymal transition (EMT), and metabolic reprogramming. The gene discussed is MTOR; the disease is cancer.